Spelling suggestions: "subject:"amyloid beta protein"" "subject:"myloid beta protein""
101 |
Fosfolipase A2, fluidez de membrana e proteína precursora do amilóide em plaquetas na doença de Alzheimer e comprometimento cognitivo leve / Phospholipase A2, membrane fluidity and amyloid precursor protein in platelets in Alzheimer\'s disease and mild cognitive impairmentZainaghi, Isis Amaral 28 February 2007 (has links)
A Doença de Alzheimer (DA) é uma desordem neurodegenerativa progressiva que causa comprometimento cognitivo em idosos. O diagnóstico clínico da DA é complexo. Existe uma grande necessidade de técnicas capazes de detectar a doença nos estágios iniciais, tanto para auxiliar o diagnóstico quanto para monitorar a efetividade dos tratamentos disponíveis. As alterações bioquímicas da DA são resultado de processos celulares como o metabolismo da proteína precursora do amilóide (APP), fosforilação da tau, stress oxidativo, inflamação e desregulação lipídica. Até o momento não existem marcadores bioquímicos para auxiliar o diagnóstico da DA. Este trabalho avaliou três possíveis candidatos a marcadores bioquímicos para a DA. Foram investigados a razão da APP (rAPP) de 130/110 kDa, fluidez de membrana e atividade da fosfolipase A2 em plaquetas de pacientes com DA e Comprometimento Cognitivo Leve (CCL), comparando-se seus resultados com controles idosos saudáveis. A fluidez das membranas das plaquetas foi avaliada por meio da anisotropia com a sonda fluorescente DPH (Difenilhexatrieno); a comparação das razões da APP foi realizada por Western Blotting empregando o anticorpo 22C11 e a da atividade da PLA2 foi determinada por ensaio radioenzimático com substratos e concentrações de cálcio específicas para cada um dos três principais grupos da enzima. A rAPP, as atividades da sPLA2 e iPLA2 estavam significantemente reduzidas na DA quando comparadas com controles, enquanto que a cPLA2 e a fluidez de membrana não apresentaram diferenças entre os grupos. A rAPP e a iPLA2 também apresentaram diferenças significativas entre CCL e DA, além de estarem correlacionadas com os parâmetros cognitivos MEEM e CAMCOG. A rAPP também estava correlacionada com a anistropia do DPH. / Alzheimer disease (AD) is a progressive neurodegenerative disorder that causes cognitive impairment in the elderly. The clinical diagnosis of AD is complex. Thus, there is a great need for sensitive techniques to detect neurodegeneration in the early stages to asset in the diagnosis and to follow the effectiveness of therapy. The biochemical alterations in the AD brain result from cellular processes such as amyloid precursor protein (APP) metabolism, tau phosphorylation, oxidative stress, inflammation and lipid dysregulation. So far there are no biochemical markers to help the AD diagnosis. The purpose of this study was to evaluate three possible candidates to biochemical marker of AD. The APP 130/110 kDa ratio, membrane fluidity and phospholipase A2 activity in platelets of patients with AD and mild cognitive impairment (MCI) were investigated compared to their results with healthy elderly controls. The membrane fluidity of platelets was assessed by the fluorescence anisotropy of DPH (diphenyl-hexatriene); the levels of APP isoforms were evaluated by Western Blot analysis using 22C11 antibody and the PLA2 activity was measured by radio-enzymatic assay with enzyme specific substrate and calcium concentrations for each one of the three main groups of the enzyme. The APP ratio (APPr), the sPLA2 and iPLA2 activity were markedly decreased in AD in comparing with controls, whereas a cPLA2 and membrane fluidity didn\'t show any alteration between the groups evaluated. The APPr and iPLA2 also showed significant differences between MCI e AD, and were correlated with cognitive parameters MMSE and CAMCOG. The APPr was also correlated with DPH anisotropy.
|
102 |
Identification and characterization of novel FE65-interacting proteins.January 2009 (has links)
Cheng, Wai Hang. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2009. / Includes bibliographical references (leaves 76-88). / Abstract also in Chinese. / Acknowledgement --- p.i / 摘要 --- p.iii / List of Abbreviations --- p.iv / List of Figures --- p.vi / List of Tables --- p.vii / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- FE65 --- p.1 / Chapter 1.1.1 --- FE65 Protein Family and Their Structures --- p.2 / Chapter 1.1.1.2 --- PTB domains --- p.5 / Chapter 1.1.2 --- Expression Pattern of FE65 Proteins --- p.6 / Chapter 1.1.3 --- FE65 Family-Transgenic Animals --- p.7 / Chapter 1.1.4 --- Interacting Partners of FE65 --- p.8 / Chapter 1.1.4.1 --- "APP, APLPl and APLP2" --- p.9 / Chapter 1.1.4.2 --- LRP1 and ApoEr2 --- p.10 / Chapter 1.1.4.3 --- c-Abl --- p.11 / Chapter 1.1.4.4 --- Mena and EVL --- p.11 / Chapter 1.1.4.5 --- Tip60 --- p.12 / Chapter 1.1.4.6 --- SET --- p.12 / Chapter 1.1.4.7 --- Estrogen Receptor a --- p.13 / Chapter 1.1.4.8 --- Teashirt --- p.13 / Chapter 1.1.4.9 --- CP2/LSF/LBP1 --- p.13 / Chapter 1.1.4.10 --- Dexra sl --- p.14 / Chapter 1.1.4.11 --- P2X2-receptor subunit --- p.14 / Chapter 1.1.4.12 --- Tau --- p.15 / Chapter 1.1.4.13 --- Notchl --- p.15 / Chapter 1.1.4.14 --- Alcadein --- p.16 / Chapter 1.1.4.15 --- CD95/Fas/Apo -1 ligand --- p.16 / Chapter 1.1.4.16 --- p68 subunit of pre -mRNA cleavage and polyadenylation factor Im (p68 CFIm) --- p.17 / Chapter 1.1.4.17 --- Ataxinl --- p.17 / Chapter 1.1.5.1 --- FE65 as an adaptor protein --- p.20 / Chapter 1.1.5.2 --- FE65 and Alzheimer´ةs disease --- p.20 / Chapter 1.1.5.3 --- Transcriptional / Post-transcriptional regulation --- p.22 / Chapter 1.1.5.4 --- Apoptosis and cell cycle regulation --- p.23 / Chapter 1.1.5.5 --- Neuronal positioning and cell migration --- p.23 / Chapter 1.1.5.6 --- Learning and memory --- p.25 / Chapter 1.2 --- Objectives --- p.26 / Chapter Chapter 2 --- Investigation of the interaction between FE65 and Arf6 --- p.27 / Chapter 2.1 --- Materials --- p.27 / Chapter 2.1.1 --- DNA contructs --- p.27 / Chapter 2.1.2 --- Cell culture --- p.27 / Chapter 2.1.3 --- Immunoblotting --- p.28 / Chapter 2.1.4 --- Miscellaneous --- p.28 / Chapter 2.2 --- Methods --- p.29 / Chapter 2.2.1 --- Preparation of Escherichia coli competent cells --- p.29 / Chapter 2.2.2 --- DNA preparation with Intron Plasmid DNA --- p.30 / Chapter 2.2.3 --- DNA preparation with Macherey-Nagel NucleoBond Xtra Midi --- p.30 / Chapter 2.2.4 --- DNA preparation by the alkaline lysis method --- p.31 / Chapter 2.2.5 --- Spectrophotometric analysis of DNA --- p.32 / Chapter 2.2.6 --- Agarose gel electrophoresis --- p.32 / Chapter 2.2.7 --- Cell culture and transfection --- p.33 / Chapter 2.2.8 --- Bacterial GST-pull down assay --- p.33 / Chapter 2.2.9 --- GST-pull down assay for testing direct interaction between FE65 and Arf6 --- p.34 / Chapter 2.2.10 --- Mammalian GST-pull down assay --- p.35 / Chapter 2.2.11 --- Immunoprecipitation --- p.36 / Chapter 2.2.12 --- SDS-PAGE --- p.36 / Chapter 2.2.13 --- Immunoblotting --- p.39 / Chapter 2.3 --- Results --- p.40 / Chapter 2.3.1 --- Interaction between Arf6 and FE65 --- p.40 / Chapter 2.3.2 --- Determination of the interacting domain of FE65 with Arf6 --- p.43 / Chapter 2.3.3 --- Determination if FE65 and Arf6 interact directly --- p.45 / Chapter Chapter 3 --- Production of Antisera against Arf6 and Immunostaining of FE65-Arf6 --- p.47 / Chapter 3.1 --- Materials --- p.47 / Chapter 3.1.1 --- Protein expression and purification --- p.47 / Chapter 3.1.2 --- Immunization and harvest of antisera --- p.48 / Chapter 3.1.3 --- Immunostaining --- p.48 / Chapter 3.2 --- Methods --- p.48 / Chapter 3.2.1 --- Protein expression and purification --- p.48 / Chapter 3.2.2 --- Bradford assay --- p.50 / Chapter 3.2.3 --- Immunization --- p.50 / Chapter 3.2.4 --- Antibody purification --- p.51 / Chapter 3.2.5 --- Immunostaining --- p.52 / Chapter 3.3 --- Results --- p.53 / Chapter 3.3.1 --- Recombinant Arf6 expression and purification --- p.53 / Chapter 3.3.2 --- Titering of antisera --- p.57 / Chapter 3.3.3 --- Determination of antisera specificity --- p.59 / Chapter Chapter 4 --- Discussion --- p.68 / Chapter Chapter 5 --- Future Perspectives --- p.73 / References --- p.76
|
103 |
Study on memapsin 2 cleavage properties and its interacting proteinsLi, Xiaoman. January 2010 (has links) (PDF)
Thesis (Ph. D.)--University of Oklahoma. / Bibliography: leaves 122-136.
|
104 |
Fosfolipase A2, fluidez de membrana e proteína precursora do amilóide em plaquetas na doença de Alzheimer e comprometimento cognitivo leve / Phospholipase A2, membrane fluidity and amyloid precursor protein in platelets in Alzheimer\'s disease and mild cognitive impairmentIsis Amaral Zainaghi 28 February 2007 (has links)
A Doença de Alzheimer (DA) é uma desordem neurodegenerativa progressiva que causa comprometimento cognitivo em idosos. O diagnóstico clínico da DA é complexo. Existe uma grande necessidade de técnicas capazes de detectar a doença nos estágios iniciais, tanto para auxiliar o diagnóstico quanto para monitorar a efetividade dos tratamentos disponíveis. As alterações bioquímicas da DA são resultado de processos celulares como o metabolismo da proteína precursora do amilóide (APP), fosforilação da tau, stress oxidativo, inflamação e desregulação lipídica. Até o momento não existem marcadores bioquímicos para auxiliar o diagnóstico da DA. Este trabalho avaliou três possíveis candidatos a marcadores bioquímicos para a DA. Foram investigados a razão da APP (rAPP) de 130/110 kDa, fluidez de membrana e atividade da fosfolipase A2 em plaquetas de pacientes com DA e Comprometimento Cognitivo Leve (CCL), comparando-se seus resultados com controles idosos saudáveis. A fluidez das membranas das plaquetas foi avaliada por meio da anisotropia com a sonda fluorescente DPH (Difenilhexatrieno); a comparação das razões da APP foi realizada por Western Blotting empregando o anticorpo 22C11 e a da atividade da PLA2 foi determinada por ensaio radioenzimático com substratos e concentrações de cálcio específicas para cada um dos três principais grupos da enzima. A rAPP, as atividades da sPLA2 e iPLA2 estavam significantemente reduzidas na DA quando comparadas com controles, enquanto que a cPLA2 e a fluidez de membrana não apresentaram diferenças entre os grupos. A rAPP e a iPLA2 também apresentaram diferenças significativas entre CCL e DA, além de estarem correlacionadas com os parâmetros cognitivos MEEM e CAMCOG. A rAPP também estava correlacionada com a anistropia do DPH. / Alzheimer disease (AD) is a progressive neurodegenerative disorder that causes cognitive impairment in the elderly. The clinical diagnosis of AD is complex. Thus, there is a great need for sensitive techniques to detect neurodegeneration in the early stages to asset in the diagnosis and to follow the effectiveness of therapy. The biochemical alterations in the AD brain result from cellular processes such as amyloid precursor protein (APP) metabolism, tau phosphorylation, oxidative stress, inflammation and lipid dysregulation. So far there are no biochemical markers to help the AD diagnosis. The purpose of this study was to evaluate three possible candidates to biochemical marker of AD. The APP 130/110 kDa ratio, membrane fluidity and phospholipase A2 activity in platelets of patients with AD and mild cognitive impairment (MCI) were investigated compared to their results with healthy elderly controls. The membrane fluidity of platelets was assessed by the fluorescence anisotropy of DPH (diphenyl-hexatriene); the levels of APP isoforms were evaluated by Western Blot analysis using 22C11 antibody and the PLA2 activity was measured by radio-enzymatic assay with enzyme specific substrate and calcium concentrations for each one of the three main groups of the enzyme. The APP ratio (APPr), the sPLA2 and iPLA2 activity were markedly decreased in AD in comparing with controls, whereas a cPLA2 and membrane fluidity didn\'t show any alteration between the groups evaluated. The APPr and iPLA2 also showed significant differences between MCI e AD, and were correlated with cognitive parameters MMSE and CAMCOG. The APPr was also correlated with DPH anisotropy.
|
105 |
First principles and proceedings of action-FRET : probing the molecular conformation of gas phase proteins and macro-ions / Premiers principes et procédures d'action - FRET : analyse de la conformation moléculaire des protéines en phase gazeuse et macro-ionsKnight, Geoffrey 13 November 2017 (has links)
Mon travail de thèse aborde différents développements physico-chimiques qui reposent sur le principe de transfert d'énergie par résonance de Foster (FRET). Le but est de parvenir à étudier et caractériser des assemblages moléculaires ainsi que des changements structurels de biomo-lécules (ou macro-ions) en phase gazeuse. Le transfert d'énergie par résonance de type Förster est un procédé par lequel de l'énergie s'échange de manière non radiative entre un chromo-phore dit donneur dans un état excité et un second chromophore accepteur en proximité di-recte. Conventionnellement, cette technique permet de localiser et déterminer l'écart entre deux molécules (de l'ordre de 10 à 100nm). Principalement utilisée pour étudier des systèmes biologiques, des résultats marquants ont été obtenus sur l'étude de système tel que l'appareil de Golgi, le cytosquelette ou les membranes cellulaires. Elle n'est cependant appliquée qu'à des systèmes en phase liquide. Il nous a paru intéressant de transposer cette technique en phase gazeuse, en utilisant la capacité des spectromètres de masse à sélectionner, isoler et activer des espèces moléculaires, nous permettant d'obtenir de nouvelles informations structurelles. Une grande partie de ma thèse a consisté à premièrement, valider le concept de FRET en phase gaz puis à développer et optimiser, la technique FRET dit ‘d'action'. L'Action-FRET est une tech-nique d'analyse par couplage de spectrométrie de masse et spectroscopie LASER mise au point par l'équipe Spectrobio afin d'étudier les molecules isolées en phase gazeuse. A travers ce dis-positif, je me suis particulièrement investi à contrôler, étudier et caractériser l'évolution des conformations de biomacromolécules d'intérêt biochimique et biologique. Dans une première partie je ferai une courte introduction générale sur les fondamentaux des protéines, de leur composition et élaboration en entités structurelles complexes, diverses et fonctionnelles. La manière dont les protéines s'arrangent successivement en niveaux structural quaternaire est aussi décrite. La deuxième partie est consacrée à une présentation des chromo-phores utilisés. Je présente ensuite leurs utilisations et détaille la synthèse des édifices molécu-laires produits pour réaliser les expériences de FRET. Ceux-ci sont constitués de composés bio-logiques (peptides ou protéines), couplés aux chromophores, (donneur-accepteur). Dans le contexte de ce chapitre se trouve également une discussion sur les mécanismes et produits uti-lisés lors de l'étape de conjugaison qui permet d'obtenir les composants désirés. En troisième partie vient un chapitre qui relate le fonctionnement des appareils utilisés dans le montage expérimental; le LASER et le spectromètre de masse. La méthode de couplage est dé-crite et spécifiée, détaillant comment les appareils commerciaux ont été modifiés pour interagir avec l'un avec l'autre. Avec ce nouveau montage, un suivi de la signature optique de FRET ap-partenant aux protéines entières greffées et à différents états de charge a été possible. Le quatrième chapitre est dédié dans les premières sections à la théorie et l'état de l'art en ce qui concerne le FRET. Les éléments emblématiques et leurs applications en solution de ces der-nières années et les travaux plus récents en phase gazeuse y sont présentés. Par ailleurs, nous avons voulu démontrer dans ce chapitre que nos diverses manipulations ont l'avantage critique de ne pas dépendre d'une mesure de l'émission de lumière suite au transfert résonant d'éner-gie. A la place, on dispose de la fragmentation spécifique de l'ion piégé du chromophore à tra-vers l'analyse de masse conventionnelle du spectromètre de masse pour détecter et quantifier une manifestation de FRET. Nous démontrerons aussi la possibilité cette méthode appliquée à la biologie moléculaire... [etc] / In this thesis, I discuss the application and development of mass spectrometry (MS) - LASER coupled techniques for the characterization and measurement of trapped biomolecules in the gas phase. In broad terms, this thesis demonstrates the potential and perspectives of action-FRET a novel structural biology tool amenable to the gas phase. The fundamentals rely on a well attested resonance quantic process known as Förster resonance energy transfer (FRET). As of yet it has been a widely utilized method to scrutinize molecular structure in solution. The mo-tivation has been to transpose this occurrence to the instrumental settings of a mass spectrom-eter, its gas confinement and, in doing so, overcome the earlier limitations of the technique and stride into the theoretical and experimental study of well determined systems as well as those whose structure were presently undetermined - all without the influence of the environment of a solvated medium. The first chapter of this thesis offers a general overview on peptides and proteins plus how they can be studied. Subsequent chapters include how the work carried out herein ads towards their study, moving the technique towards a gold standard of native mass spectrometry (native MS). In the second chapter, a treatment of the synthetic steps and preparations is given detailing the mechanistics of the reactions at play and above all outlining the experimental procedures and providing any information on any observations made. The third chapter describes, and is devoted to an introduction of the instrumental setup outlaid as it stands giving an account on the LASER, optical pieces and the mass spectrometer employed throughout the course of this thesis, effectively setting the premises of thought and understand-ing for subsequent chapters and methodology. Chapter four presents energy transfer, in particular to the Foster Resonance Energy Transfer and furthermore outlines the developed technique central to the mass spectrometry method to look at donor-acceptor chromophores espoused to biomolecular systems and their photofrag-ments — what is nicknamed as action-FRET. Chapter five reviews and discusses the study of a macromolecule: Ubiquitin, by action-FRET. The first gas phase experiment on the protein to have ever been realised. The information and content gathered from this adapted experiment is compared to work found elsewhere giving an appraisal on the potential of action-FRET and providing an idea to what future insights the technique could bring. In chapter six the reader is introduced to the project of establishing action-FRET in the negative mode of the mass spectrometer’s ionization source as opposed to its positive mode. Suitable pairs of donor-acceptor chromophores to validate the energy transfer under a negative regime were explored. These where profiled and characterized before being adapted to a biomolecular system. The results provide a different flavor of complimentary structural and conformation information, the first of its kind for negative mode action-FRET. The seventh and final chapter is devoted to future developments. The conclusive work tends to grant a further understanding of neurodegenerative diseases that afflict our societies. Chiefly that of the likes of Alzheimer’s: it’s the mechanism of action pertinent to other neurodegenera-tive pathologies; Parkinson’s, Huntington’s but also prion diseases or amyloid neuropathy. In doing so a contribution is presented on a way to trace a strategy in how to tackle and treat such diseases
|
106 |
Etude pluridisciplinaire de peptides liés à la maladie d'Alzheimer: de la protéine précurseur de l'amyloïde (APP) aux oligomères de beta-amyloïde et aux inhibiteurs de gamma-sécrétase / Multidisciplinary study of Alzheimer's disease-related peptides: from amyloid precursor protein (APP) to amyloid beta-oligomers and gamma-secretase modulatorsItkin, Anna 14 May 2012 (has links)
La maladie d'Alzheimer (AD) est un désordre neurodégénératif progressif et la forme la plus commune de démence. A l’heure actuelle, il n'y a aucun remède et la maladie est toujours fatale. Une des caractéristiques histopathologiques de l'AD est la présence de dépôts protéiques, les plaques amyloïdes, dans le cerveau. Ces plaques sont formées par les peptides amyloïdes β (Aβ) de 40 et 42 résidus, qui sont les produits de clivage par des protéases de la protéine précurseur de l’amyloïde (l'APP). L'élucidation de certains des processus clés dans la cause et le développement de l'AD est une étape cruciale pour le développement de traitements nouveaux et efficaces.<p><p>Les propriétés conformationnelles du segment transmembranaire (TM) de l’APP peuvent affecter sa protéolyse par la γ-sécrétase. Ces propriétés ne sont pas encore clairement établies. Afin de comprendre le rôle des variations structurelles du TM dans le traitement de l'APP, des détails structurels des peptides APP_TM4K, chimiquement synthétisés, ont été étudiés dans la bicouche lipidique en utilisant la réflexion totale atténuée par spectroscopie infrarouge à transformée de Fourier (ATR-FTIR) et la résonance magnétique nucléaire à l’état solide (ssNMR). Tandis que la structure secondaire globale du peptide APP_TM4K est hélicoidale, une hétérogénéité conformationnelle et orientée a été observée pour le site de clivage γ et, dans une plus faible mesure, pour le site de clivage ζ. Ces variabilités conformationnelles autour des sites de clivage γ et ζ peuvent avoir des implications importantes dans le mécanisme de clivage et donc dans la production d’Aβ. Il a été aussi démontré que la dernière glycine dans le motif de dimérisation GxxxG est transmembranaire. Ceci peut impliquer que la dimérisation via ce motif pourrait servir d’ancrage et conférer une orientation transmembranaire stable au segment transmembranaire de l’APP.<p><p>Le peptide amyloïde β est directement lié à la maladie d’Alzheimer. Partant de sa forme monomérique, l’Aβ s'agrège pour produire en final des fibrilles et aussi de manière transitoire toute une gamme d'oligomères, ces derniers étant la plupart neurotoxiques. Une dérégulation de l’homéostasie du Ca2+ dans le cerveau vieillissant et dans des troubles neurodégénératifs joue un rôle crucial dans de nombreux processus et contribue au dysfonctionnement et à la mort cellulaire. Nous avons postulé que le calcium peut permettre ou accélérer l'accumulation d'Aβ. Le modèle d'accumulation d'Aβ (1-40) et celui d'Aβ (1-40) E22G, un peptide amyloïde portant la mutation arctique qui cause une apparition prématurée de la maladie, ont été comparé. Nous avons constaté qu'en présence de Ca2+, l’Aβ (1-40) forme de préférence des oligomères semblables à ceux formés par l’Aβ (1-40) E22G avec ou sans Ca2+, tandis qu'en absence de Ca2+ l'Aβ (1-40) s’agrège sous forme de fibrilles. Les ressemblances morphologiques entre oligomères ont été confirmées par microscopie de force atomique. La distribution des oligomères et des fibrilles dans des échantillons différents a été détectée par électrophorèse sur gel suivie d’une analyse par Western blot, dont les résultats ont été confirmés par des expériences de fluorescence à la thioflavine T. Dans les échantillons sans Ca2+, l’ATR-FTIR révèle la conversion des oligomères en feuillets β antiparallèles en la conformation caractéristique des fibrilles en feuillets β parallèles. En général, ces résultats nous ont ameré à conclure que les ions calcium stimulent la formation d'oligomères d'Aβ (1-40), qui sont impliqués dans la pathogénèse d'AD.<p><p>Malgré les progrès énormes obtenus dans la compréhension de la maladie (AD), il reste un défi majeur, celui du développement de médicaments nouveaux et efficaces. Afin d’obtenir des éclaircissements sur le mécanisme d'action de deux nouveaux puissants modulateurs de la γ-sécrétase - le benzyl-carprofen et le sulfonyl-carprofen dans la bicouche lipidique, la technique de RMN à l’état solide a été employée. Précédemment, les dérivés du carprofen ont été localisés dans des membranes de lipides par des expériences de diffusion (scattering) des neutrons. Les contraintes déterminées à partir des expériences de ssNMR ont permis d’affiner leurs positions et d’obtenir une orientation précise dans la double couche lipidique. Ces résultats combinés indiquent que le mécanisme probable de modulation du clivage par la γ-sécrétase est une interaction directe des carprofènes avec le domaine TM de l’APP. Une telle interaction, empêcherait à la formation de dimères d'APP, dimérisation nécessaire au clivage séquentiel par la γ-sécrétase, diminuant ou réduisant ainsi énormément la production d’Aβ, tout particulièrement d’Aβ42.<p><p>Les résultats de ce travail apporte de nouvelles informations sur les processus clés impliqués dans l'AD; Production de l'Aβ à partir de l'APP, formation des oligomères d'Aβ et mécanisme d'action potentiel de molécules thérapeutiques. Nous pensons que ces résultats pourront permettre une meilleure compréhension de la maladie et pourront aider dans la conception de nouveaux médicaments contre cette maladie.<p><p>Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common form of dementia. There is no cure and the disease is fatal. One of the characteristic histopathological markers of AD is the presence of proteinaceous deposits, amyloid plaques, in the brain. These plaques are formed by the amyloid β-peptides (Aβ) 40- and 42-residue-long, which are protease cleavage products of the amyloid precursor protein (APP). Elucidation of some of the key processes in the cause and the development of AD is crucial for the development of new and efficient treatments.<p><p>Conformational properties of the transmembrane (TM) segment of APP may affect its proteolytic processing by γ-secretase. These properties have not been definitely established. In addressing the role of structural variations of the TM sequence in APP processing, structural details of the chemically synthesized APP_TM4K peptides within the membrane bilayers were studied using Attenuated total reflection Fourier transform spectroscopy (ATR-FTIR) and solid-state nuclear magnetic resonance (ssNMR) techniques. While the overall secondary structure of the APP_TM4K peptide is an α-helix, conformational and orientational heterogeneity was observed for the γ-cleavage site and, to a smaller extent, for the ζ-cleavage site. Evidence for the conformational variability around γ- and ζ-cleavage sites may have important implications for the cleavage mechanism and hence for the Aβ production. It was also found that the last glycine within the sequence of GxxxG motifs is in the transmembrane orientation, implying that dimerization via these motifs may act as an anchor, confining the TM dimer to the stable transmembrane orientation. <p><p>Amyloid β-peptide is directly linked to AD. Starting from its monomeric form, Aβ aggregates into fibrils and / or oligomers, the latter being the most neurotoxic. Dysregulation of Ca2+ homeostasis in aging brains and in neurodegenerative disorders plays a crucial role in numerous processes and contributes to cell dysfunction and death. Here we postulated that calcium may enable or accelerate the aggregation of Aβ. The aggregation pattern of Aβ(1-40) and of Aβ(1-40)E22G, an amyloid peptide carrying the Arctic mutation that causes early onset of the disease, were compared. We found that in the presence of Ca2+, Aβ(1-40) preferentially formed oligomers similar to those formed by Aβ(1-40)E22G with or without added Ca2+, whereas in the absence of added Ca2+ the Aβ(1-40) aggregated to form fibrils. Morphological similarities of the oligomers were confirmed by contact mode atomic force microscopy (AFM) imaging. The distribution of oligomeric and fibrillar species in different samples was detected by gel electrophoresis and Western blot analysis, the results which were further supported by thioflavin T fluorescence experiments. In the samples without Ca2+, Fourier transform infrared spectroscopy revealed conversion of oligomers from an anti-parallel β-sheet to the parallel β-sheet conformation characteristic of fibrils. Overall, these results led us to conclude that calcium ions stimulate the formation of oligomers of Aβ(1-40), that have been implicated in the pathogenesis of AD. <p><p>Despite the tremendous progress in understanding AD, there remains the challenge of the development of new and efficient drugs. In order to shed light onto the mechanism of action of two new potent γ-secretase modulators -- benzyl-carprofen and sulfonyl-carprofen within lipid bilayers, ssNMR technique was employed. Using neutron scattering experiments it was previously found that sulfonyl-carprofen and benzyl-carprofen partition into the headgroup region of the lipid bilayer. The orientational constraints derived from the ssNMR experiments refined their position into precise orientation. Combined, these results indicate that carprofen-derivatives can directly interact with the region of APP that mediates dimerization. Such interaction, would interfere with proper APP-dimer formation, which is necessary for the sequential cleavage by γ-secretase, diminishing or greatly reducing Aβ42 production.<p><p>Results obtained during this work shed new light onto some of the key processes in AD: Aβ production from APP, formation of Aβ oligomers and insights into the mechanism of action of potential therapeutics. We believe that these results will promote a better understanding of the disease and will help in future drug design.<p> / Doctorat en Sciences / info:eu-repo/semantics/nonPublished
|
107 |
Advanced optical techniques to study biomolecular aggregation processesQuinn, Steven D. January 2014 (has links)
Alzheimer's disease (AD) is characterised by a series of biomolecular aggregation events, which include the formation of neurotoxic protein structures composed of the β-amyloid (Aβ) peptide. In this thesis, fluorescence self-quenching (FSQ) between fluorescently-labelled peptides is introduced as a strategy for detecting and characterizing Aβ aggregates in solution, and for overcoming limitations associated with conventional methods. Using a combination of steady-state, picosecond time-resolved fluorescence and transmission electron microscopy, the fluorescence response of HiLyte Fluor 555-labelled Aβ peptides is characterised to demonstrate that Aβ self-assembly organizes the covalently attached probes in close proximity to trigger the self-quenching sensing process over a broad range of conditions. Importantly, N-terminal tagging of β-amyloid peptides is shown to not alter the self-assembly kinetics or the resulting aggregated structures. When performed in Förster resonance energy transfer (FRET) format, this method becomes a ratiometric platform to gain insights into amyloid structure and for standardizing in vitro studies of amyloid self-assembly. The ability of FSQ-based methods to monitor the inhibition of Aβ aggregation by model test compounds including the small heat shock protein (Hsp), the amyloid-binding alcohol dehydrogenase protein (ABAD) and bovine serum albumin (BSA) is also demonstrated. Given that Aβ is formed within the cell membrane and is known to induce its disruption, sophisticated single-molecule fluorescence spectroscopy methods were developed to quantify membrane dynamics induced by the presence of disrupting agents, such as Aβ and detergents. The solubilisation dynamics of single liposomes induced by the non-ionic surfactant Triton-X 100 (TX-100) were studied in real-time. Using this approach, the swelling and permeabilization steps of the solubilisation process were unambiguously separated within single FRET trajectories, and their kinetic details as a function of Triton-X 100 and presence of cholesterol within the membrane structure were examined. Finally, single-molecule stepwise-photobleaching techniques were employed to study the effect of Aβ oligomers interacting with supported-lipid bilayers, establishing a platform from which to investigate how the presence of a membrane layer affects Aβ oligomerization at the level of individual molecules. Overall, the fluorescence-based strategies for amyloid- and liposome-sensing presented in this work bridges the gap between current morphology-specific techniques and highly-specialized single-molecule methods to provide a biophysical toolbox to investigate the changes in structure, size and molecular interactions accompanying the amyloid aggregation pathway and for the screening of novel therapeutic and diagnostic agents.
|
108 |
The Impact of Causative Genes on Neuropsychological Functioning in Familial Early-Onset Alzheimer's Disease: A Meta-AnalysisSmotherman, Jesse M. 05 1900 (has links)
Mutations of three genes encoding amyloid precursor protein (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2) have been shown to reliably result in familial early-onset Alzheimer's disease (FAD); a rare, but catastrophic, subtype of Alzheimer's disease (AD) marked by symptom emergence before age 65 as well as accelerated cognitive deterioration. The current study represents the first known meta-analysis on the association of APP, PSEN1 or PSEN2 on neurocognitive variables. A total of 278 FAD mutation-carriers (FAD-MC) and 284 cognitively healthy non-mutation-carriers (NC) across 10 independent investigations meeting inclusion criteria were chosen for the current meta-analysis (random effects design). Findings revealed an overarching trend of poorer performance by FAD-MC individuals compared to NC individuals across the majority of cognitive domains identified. Significant differences in effect sizes suggested FAD-MC individuals exhibited worse performance on measures of attention, explicit memory, fluency, primary memory, verbal, and visuospatial functioning. Findings indicative of differential sensitivity to cognitive domain impairments across FAD-MC and NC groups inform neuropsychological descriptions of individuals in preclinical phases of FAD.
|
109 |
Neuroprotective effects of the active principles from selected Chinese medicinal herbs on b-amyloid-induced toxicity in PC12 cells.January 2007 (has links)
Hoi, Chu Peng. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2007. / Includes bibliographical references (leaves 81-103). / Abstracts in English and Chinese. / Acknowledgements --- p.II / Abstract --- p.III / Abstract (in Chinese) --- p.V / List of Abbreviations --- p.VI / List of Figures --- p.VIII / List of Tables --- p.X / Table of Contents --- p.XI / Chapter Chapter One --- General introduction --- p.1 / Chapter 1.1 --- Alzheimer's disease --- p.1 / Chapter 1.1.1 --- Epidemiology and risk factors --- p.2 / Chapter 1.1.2 --- Clinical manifestation and course --- p.4 / Chapter 1.1.3 --- Clinical diagnosis --- p.5 / Chapter 1.1.4 --- Neuropathology and pathogenesis of AD --- p.8 / Chapter 1.1.5 --- Drug therapy of AD --- p.11 / Chapter 1.1.5.1 --- Drugs for symptomatic treatment --- p.11 / Chapter 1.1.5.2 --- Drugs based on epidemiology --- p.12 / Chapter 1.1.5.3 --- Drugs with potential disease-modifying effects --- p.14 / Chapter 1.1.5.4 --- Herbal supplements --- p.15 / Chapter 1.2 --- Models for drug discovery in Alzheimer Disease --- p.15 / Chapter 1.2.1 --- In vivo (animal) models --- p.16 / Chapter 1.2.2 --- In vitro (cellular) models --- p.18 / Chapter 1.3 --- Chinese herbs for the treatment of AD --- p.20 / Chapter 1.3.1 --- Ginkgo biloba L --- p.21 / Chapter 1.3.2 --- Magnolia officinalis --- p.24 / Chapter 1.3.3 --- Acori graminei Rhizoma (AGR) --- p.26 / Chapter 1.3.4 --- Gastrodia elata (G. elata) --- p.27 / Chapter 1.3.5 --- Rhodiola rosea L.( R. rosea) --- p.29 / Chapter 1.3.6 --- Scutellariae baicalensis --- p.30 / Chapter 1.3.7 --- Curcuma longa L.(Zingiberaceae) --- p.31 / Chapter 1.4 --- Aims of the study --- p.33 / Chapter Chapter Two --- Materials and Methods --- p.34 / Chapter 2.1 --- Materials --- p.34 / Chapter 2.1.1 --- Chemicals and reagents --- p.34 / Chapter 2.1.2 --- Materials for cell culture --- p.35 / Chapter 2.1.3 --- Instruments --- p.35 / Chapter 2.2 --- Methods --- p.36 / Chapter 2.2.1 --- Cell culture --- p.36 / Chapter 2.2.2 --- MTT cell viability assay --- p.38 / Chapter 2.2.3 --- Characterization of the cytotoxicity of Aβ peptide in NGF-differentiated PC 12 cells --- p.38 / Chapter 2.2.4 --- Screening of the neuroprotective effect of major principles from selected herbs on PC 12 cells against Aβ-induced cytotoxicity --- p.39 / Chapter 2.2.5 --- Measurement of reactive oxygen species (ROS) --- p.40 / Chapter 2.2.6 --- Measurement of intracellular calcium levels --- p.41 / Chapter 2.2.7 --- Measurement of caspase-3 activity --- p.42 / Chapter 2.2.8 --- Propidium iodide (PI) staining to evaluate apoptosis and necrosis --- p.43 / Chapter 2.3 --- Statistics --- p.45 / Chapter Chapter Three --- Results --- p.46 / Chapter 3.1 --- NGF-differentiated PC 12 cells --- p.46 / Chapter 3.1.1 --- Determination of an appropriate cell density for the screening experiments --- p.46 / Chapter 3.1.2 --- Characterization of Aβ-induced cytotoxicity in NGF-differentiated PC 12 cells --- p.47 / Chapter 3.1.2.1 --- Cytotoxicity of Aβ-related fragments in NGF-differentiated PC 12 cells --- p.48 / Chapter 3.1.2.2 --- Dose-dependent cytotoxic effect of Aβ on PC 12 cells --- p.48 / Chapter 3.1.2.3 --- Time-dependent effect of Aβ-induced toxicity on PC12 cells --- p.50 / Chapter 3.1.3 --- Protective effect of selected active principles against Aβ1-4-induced toxicity in PC 12 cells --- p.51 / Chapter 3.2 --- Measurement of reactive oxygen species (ROS) --- p.54 / Chapter 3.2.1 --- Measurement of ROS induced by H202 --- p.54 / Chapter 3.2.2 --- Measurement of ROS induced by Aβ --- p.56 / Chapter 3.3 --- Measurement of Intracellular calcium levels --- p.57 / Chapter 3.4 --- Measurement of caspase-3 activity --- p.58 / Chapter 3.4.1 --- AMC reference standard curve --- p.59 / Chapter 3.4.2 --- Measurement of caspase-3 activity --- p.59 / Chapter 3.5 --- PI staining for evaluate apoptosis and necrosis --- p.60 / Chapter Chapter Four --- Discussion --- p.64 / Chapter 4.1 --- Aβ-induced cytotoxicity in NGF-differentiated PC 12 cells as an in vitro model of Alzheimer's disease --- p.64 / Chapter 4.1.1 --- Cell line selection --- p.65 / Chapter 4.1.2 --- Characterization of Aβ-induced cytotoxicity in NGF-differentiated PC 12 cells --- p.66 / Chapter 4.2 --- Screening of the neuroprotective effects of selected active principles against Aβ-induced cytotoxicity in NGF-differentiated PC 12 cells --- p.67 / Chapter 4.3 --- Neuroprotection via inhibition of the ROS generation --- p.71 / Chapter 4.4 --- Neuroprotection via suppression of calcium homeostasis --- p.73 / Chapter 4.5 --- Neuroprotective via inhibition of Aβ-induced apoptosis --- p.75 / Chapter 4.5.1 --- Inhibition of caspase-3 activation --- p.75 / Chapter 4.5.2 --- PI staining for evaluation of apoptosis and necrosis --- p.76 / Chapter Chapter Five --- Conclusion and future work --- p.79 / Chapter 5.1 --- Conclusion --- p.79 / Chapter 5.2 --- Future work --- p.80 / References --- p.81
|
110 |
Towards an early diagnosis of Alzheimer's disease: development of an ATR-FTIR biosensor for the detection of Abeta toxic conformations / Développement d'un biosenseur ATR-FTIR, spécifique aux conformations toxiques du peptide amyloide beta impliqué dans la maladie d'AlzheimerKleiren, Emilie 09 September 2013 (has links)
As the most prevalent cause of dementia worldwide, Alzheimer’s disease (AD) has become a global issue of public health. By current criteria, diagnosis of this neurodegenerative disorder requires both clinical confirmation of dementia and post-mortem detection of the so-called neurofibrillary tangles and senile plaques in the brain. Yet the main proteinaceous component of these plaques, the amyloid beta peptide (Abeta) is now widely believed to initiate a cascade of events that ultimately leads to Alzheimer’s disease. Besides, extensive evidence supports a pathogenic role of soluble oligomers formed upon Abeta aggregation in the onset of the disease, which, unlike Abeta fibrils, present distinct neurotoxic properties and correlate well with disease progression. Their detrimental effects have been suggested to appear decades before the first signs of cognitive impairment, making them biomarkers of choice in the study of the pathology. <p>Given that present guidelines for AD diagnosis are increasingly considered as ill-defined, reliable and early-stage detection methods taking into account the presence of toxic Abeta species are highly awaited by the medical community. In this regard, this thesis work describes the development of a sensing device aiming at the specific detection of the amyloid beta peptide in solution via recognition by antibodies grafted at the surface of functionalized germanium crystals. This new type of BIA-ATR (Biospecific Interaction Analysis - Attenuated Total Reflection) biosensor resorts on ATR-FTIR (Attenuated Total Reflection - Fourier Transform Infrared) spectroscopy, which is extremely sensitive to the secondary structure of proteins. The ATR mode uses germanium as optical transduction element combined to the evanescent wave principle to allow selective online monitoring of peptide-antibody binding events. <p>In the first part of this work, evaluation of the photochemistry on germanium optical elements have been the subject of intense research focus. Our investigations led to the elaboration of a quality control of functionalization efficiency based on infrared spectroscopy. We also set up in the lab an original ELISA method for selecting antibodies in terms of their true affinity for the Abeta peptide. <p>Thereafter binding experiments were carried out on the BIA-ATR sensor using different antibodies and Abeta isoforms, leading to the establishing of a standardized protocol for the detection of molecules of interest. Our results showed that Abeta detected on the biosensor corresponded precisely to antibody-bound peptide, whereas Abeta assemblies, and especially Abeta 1-42 oligomeric conformations, could be discriminated with respect to their spectral signature. This point, which was later confirmed by unsupervised statistical analysis, could be considered as particularly interesting and innovative, since to our knowledge, such conformation-sensitivity has never been observed with existing AD diagnostic methods. Moreover, effective recycling of the functionalized crystals has been demonstrated, which confers thereby a second major advantage to the biosensor. <p>In parallel to these experiments, a structural characterization study of Abeta species was undertaken in order to generate a database of IR spectra, as reference for future comparative analysis of physiological fluids on the biosensor. ATR-FTIR measurements revealed a strong dependency on the ratio between oligomers and fibrils within a mixture and their relative ratio in antiparallel and parallel beta-sheet content. Interestingly, separation trials of oligomeric entities demonstrated a specific effect of Cu2+ ions on Abeta aggregation. Stabilization of small oligomeric aggregates at equimolar Cu2+:Abeta ratios, which had never been clearly evidenced so far, could help to unravel some aspects of the complex role of copper in AD development. <p>These investigations illustrate the applicability of the so-called BIA-ATR methodology to online detection of different forms of the Abeta peptide in solution and the potential of this new sensor technology to fulfill current pitfalls in providing a reliable and comprehensive approach of AD diagnosis. / Doctorat en Sciences agronomiques et ingénierie biologique / info:eu-repo/semantics/nonPublished
|
Page generated in 0.0626 seconds